Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a ‘living’ and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CARs to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Asmamaw Dejenie, Tadesse, Tiruneh G/Medhin, Markeshaw, Dessie Terefe, Gashaw, Tadele Admasu, Fitalew, Wale Tesega, Wondwossen, Chekol Abebe, Endeshaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746433/
https://www.ncbi.nlm.nih.gov/pubmed/36094837
http://dx.doi.org/10.1080/21645515.2022.2114254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746433/
https://www.ncbi.nlm.nih.gov/pubmed/36094837
http://dx.doi.org/10.1080/21645515.2022.2114254

Ejemplares similares